Clinical Trial Update: Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating locoregional or systemic administration of autologous tumor-infiltrating lymphocytes in patients with metastatic melanoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Uveal Melanoma

Drugs mentioned

• Autologous tumor-infiltrating lymphocytes (TIL) therapy (tumor-infiltrating lymphocytes)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma | Phase 1 | Status: NOT_YET_RECRUITING